We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.
That is why we come to work each day. We commit ourselves to scientific rigour, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.
We are proud of who we are, what we do, and how we do it. We are many, working as one across functions, across companies, and across the world.
We are Roche.
Translational Medicine Leader
The Translational Medical Leader (TML) is a core member of the well-established Oncology Translational Medicine Organization, working in the Translational Science Group. The TML leads the exploratory medicine strategy for multiple early oncology drug assets. He / She is the key medical expert on the early Global Discovery Team and ensures alignment of the development strategy with the overall Roche/GNE disease area strategy. The TML owns and drives the exploration of clinical-translation data to design the clinical development strategy for new compounds (both small and large molecules).
Shapes the hypotheses to be tested pre-clinically to facilitate entry into human clinical phase
Represents the main interface between Oncology Translational Medicine and Oncology Discovery for project- and program-related activities
Supports target and clinical candidate selection, be accountable for the design and the clinical and scientific content of experimental medicine studies to evaluate and validate targets
Proposes, establishes and leads external collaborations to address strategic and tactical needs
Works with the Biomarker Experimental Medicine Leader to develop biomarker strategies
Reports to Head of Translational Science
As the ideal candidate, you bring solid experience in clinical oncology and overall knowledge of the broad research and drug development process in oncology. You are medically qualified (MD), ideally combined with a PhD. You have a proven record of scientific achievement with significant experience in drug development documented by presentations and publications in peer reviewed Journals
Additionally, you have the following skills/ expertise:
Patient-related clinical experience as investigator on Phase I/II studies
Industry experience (minimum 2-3 years) preferred
Enjoy thinking strategically beyond current standard of care and at the same time able to work hands on
A positive mindset and understanding of the challenges and uncertainty of early medical research
Proactive, very flexible attitude, and you can adapt easily to change
Excellent communication skills and fluency in English
An independent working style, and you are also a strong team player
You have the ability to independently develop the clinical strategy for exploratory development
You work as experienced matrix leader and decision maker with strong leadership skills to influence and motivate Teams
You have an understanding of contemporary translational research tools, including imaging, biomarkers and an understanding of unmet medical needs in oncology and ability to think beyond current paradigms of care
You have an analytical thinking and a high level of business awareness
At Roche, 94,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity
Roche ist ein Arbeitgeber, bei dem Chancengleichheit zählt.